The world today faces a paradox in healthcare. While medical science has advanced more in the last decade than in the previous fifty years, access to essential medicines remains uneven across geographies. According to the World Health Organization, nearly 2 billion people worldwide lack access to essential medicines, with the gap most pronounced in emerging economies and semi-regulated markets. Simultaneously, the cost of drug development has skyrocketed—bringing a new medicine to market now costs an average of $1.3 billion and takes 10-15 years from discovery to patient access.
Healthcare inequality is one of the most pressing challenges of our time. Across the world, millions of people living in rural and remote regions struggle to access even basic medical care